Muse cell known as a kind of Stem cell enabled therapy for SARS-CoV-2-Lung and Olfactory Impairment in Syrian Hamsters and may also have therapeutic effects for long COVID
Authors:
- Jun FujiiJFJun Fujii
- Satoshi ShibataSSSatoshi Shibata
- Hiroshi ItoHIHiroshi Ito
- Toshihiro ItoTIToshihiro Ito
- Shohei WakaoSWShohei Wakao
- Hiroko HagiwaraHHHiroko Hagiwara
- Kaori YasudaKYKaori Yasuda
- Naoya OharaNONaoya Ohara
- Toyoshi YanagiharaTYToyoshi Yanagihara
- Akihiro MatsukawaAMAkihiro Matsukawa
- Masayoshi FujisawaMFMasayoshi Fujisawa
Preprint
- 1 February 2026
- preprint
- Published by Springer Nature in Research Square
Abstract
Background Long COVID, including symptoms such as asthma, allergies, musculoskeletal pain, diabetes, insomnia, headaches, chronic fatigue, and frailty persisting for at least 2 months following acute SARS-CoV-2 infection, is a global health concern with no established treatments. While some studies demonstrated efficacy using mesenchymal stem cells (MSCs), outcomes have been inconsistent. Methods In the present study, we evaluated a small, distinct subset of SSEA-3(+) MSCs, known as multilineage-differentiating stress-enduring (Muse) cells, in a preclinical model of SARS-CoV-2 infection. Here, in a Syrian hamster model of SARS-CoV-2 infection, Syrian hamsters were intranasally inoculated with SARS-CoV-2 on day 0, and then on day 2, the hamsters were intravenously administered Muse cells, non-Muse cells, or vehicle (saline). On day 8, the hamsters were sacrificed, and the lungs and olfactory bulb (OB) were removed from the body to perform the experiments including inflammatory response, apoptosis, fibrosis (lung only). At the same time, total RNA was extracted from the lung and OB for RNA-seq and IPA analysis. Results We demonstrated that intravenous treatment with human-bone marrow-derived Muse cells more effectively reduced inflammation, fibrosis, and apoptosis than non-Muse-MSCs while preserving oxygen saturation, body weight, lung and olfactory bulb structure, and alveolar air space. RNA sequencing identified 64 differentially expressed genes associated with Muse cell-mediated tissue protection, with distinct profiles in olfactory bulb and lung tissues. Although this study does not directly assess long COVID, the marked suppression of severe COVID-associated pathology suggests that Muse cell treatment holds promise as a potential therapeutic approach for long COVID. Conclusions Our findings demonstrated that Muse cells suppressed the expression of inflammatory, apoptosis, fibrosis mediators that may exacerbate severe COVID-19 pathology as ARDS. Some reports suggest that SARS-CoV-2 infection in the olfactory bulb provides a route for SARS-CoV-2 viral invasion of the brain, leading to neurologic symptoms of long COVID. Therefore, we propose that Muse cells could ameliorate both pulmonary and neurologic components of long COVID by suppressing key inflammatory and fibrotic pathways. Because Finally, these findings suggest that Muse cells may be a promising therapeutic approach for mitigating the symptoms of severe COVID-19 infection and preventing long COVID.Keywords
All Related Versions
This publication has 55 references indexed in Scilit:
- Human umbilical cord‐derived mesenchymal stem cell transplantation improves the long COVIDJournal of Medical Virology, 2024
- Real-world effectiveness of sotrovimab for the treatment of SARS-CoV-2 infection during Omicron BA.2 and BA.5 subvariant predominance: a systematic literature reviewInfection, 2024
- Stem Cell Extracellular Vesicles as Anti-SARS-CoV-2 Immunomodulatory Therapeutics: A Systematic Review of Clinical and Preclinical StudiesStem Cell Reviews and Reports, 2024
- Olfactory dysfunction in COVID-19: new insights into the underlying mechanismsTrends in Neurosciences, 2022
- Phagocytosing differentiated cell-fragments is a novel mechanism for controlling somatic stem cell differentiation within a short time frameCellular and Molecular Life Sciences, 2022
- Virome characterization of game animals in China reveals a spectrum of emerging pathogensCell, 2022
- Elevated Calprotectin and Abnormal Myeloid Cell Subsets Discriminate Severe from Mild COVID-19Cell, 2020
- Study of the protective effect on damaged intestinal epithelial cells of rat multilineage‐differentiating stress‐enduring (Muse) cellsCell Biology International, 2019
- Umbilical Cord-Derived Mesenchymal Stromal Cells (MSCs) for Knee Osteoarthritis: Repeated MSC Dosing Is Superior to a Single MSC Dose and to Hyaluronic Acid in a Controlled Randomized Phase I/II TrialStem Cells Translational Medicine, 2018
- In vitro differentiation of human multilineage differentiating stress-enduring (Muse) cells into insulin producing cellsJournal of Genetic Engineering and Biotechnology, 2018